Drug Shortage Report for GABAPENTIN TABLETS USP
Report ID | 40647 |
Drug Identification Number | 02392526 |
Brand name | GABAPENTIN TABLETS USP |
Common or Proper name | GABAPENTIN |
Company Name | ACCORD HEALTHCARE INC |
Market Status | MARKETED |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 600MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 TABS PER BOTTLE | BOUTEILLE DE 100 COMPRIMÉS |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-02-02 |
Estimated end date | 2018-03-09 |
Actual end date | 2018-03-16 |
Shortage status | Resolved |
Updated date | 2018-03-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-03-22 | French | Compare |
v3 | 2018-03-22 | English | Compare |
v2 | 2018-02-22 | French | Compare |
v1 | 2018-02-22 | English | Compare |
Showing 1 to 4 of 4